je.st
news
Tag: clinical
Bovine Lymphosarcoma: Few Cows Show Clinical Signs Of Cattle Disease
2014-10-10 11:00:00| Beef
There are multiple forms of bovine lymphoma/lymphosarcoma (different names, same disease). The forms are classified by age of onset, location of the tumors and frequency of occurrence in a population. Vet's Opinion read more
Tags: show
disease
signs
clinical
NUUU Announces the Results of a Clinical Study that Tested the...
2014-10-10 00:17:58| Jewelry - Topix.net
Technology Applications International Corporation announced today that they a concluded a clinical study to test the efficacy of their products at Essex Testing Clinic in Verona, NJ. The Essex Testing Clinic staff includes PhDs, nurses, clinical study, quality assurance and recruitment professionals, trained evaluators and a large network of consulting physicians, all of whom have extensive experience in clinical investigation.
Tags: the
results
study
tested
New Anti-Aging Clinical Studies Test for Efficacy in Transforming...
2014-10-09 16:31:40| Jewelry - Topix.net
Company Announces Recent Results of Clinical Studies for RE'JUVEL Line of Anti-Aging Products that use NASA* Patented Technology Skin-Care developments & extensive Clinical Trials advancements in Anti-Aging Industry lead to robust gains within Personal Products Sector. Companies in focus today are: Technology Applications International Corporation , Coty Inc. , Nu Skin Enterprises Inc. , Technology Applications International Corporation announced today that they a concluded a clinical study to test the efficacy of its wholly owned Subsidiary's Rejuvel Line of Anti-Aging Products that use NASA* Patented Technology at Essex Testing Clinic in .
Tags: test
studies
clinical
efficacy
Merck to Present New Data from Clinical Studies Evaluating Investigational Hepatitis C Treatment Grazoprevir/Elbasvir (MK-5172/MK-8742) at the 65th American Association for the Study of Liver Diseases Annual Meeting
2014-10-08 17:13:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. Interim results of C-SWIFT, a Phase 2 study evaluating ultra-short treatment durations of grazoprevir/elbasvir (MK-5172/MK-8742) plus sofosbuvir, to be presented Results from the C-WORTHy study, a Phase 2 clinical trial evaluating grazoprevir/elbasvir (MK-5172/MK-8742) across multiple patient populations, including difficult-to-cure, to be presented WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that new data from clinical studies of the companys investigational, oral, once-daily, fixed-dose combination chronic hepatitis C treatment grazoprevir/elbasvir (MK-5172/MK-8742) are scheduled to be presented at the 65th American Association for the Study of Liver Diseases (AASLD) Annual Meeting, also known as The Liver Meeting. The meeting is scheduled to take place at the John B. Language: English Contact: MerckMedia:Pam Eisele, 267-305-3558Sarra Herzog, 201-669-6570orInvestors:Joe Romanelli, 908-423-5185Justin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: of
data
present
american
LabConnect Uses Custom Approach To Enhance Clinical Data Mining
2014-10-01 13:39:02| drugdiscoveryonline Home Page
LabConnect, LLC., a leading provider of central laboratory services to the biopharmaceutical industry, announces the release of its BioVisualization software platform
Tags: data
approach
custom
clinical
Sites : [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] next »